Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1998-4-2
|
| pubmed:abstractText |
Elevated maternal serum human chorionic gonadotropin (hCG) is an important marker of Down syndrome. Notably, women with unexplained elevated serum hCG in the second trimester experience a 2- to 5-fold increase risk of preeclampsia. Urinary gonadotropin peptide (UGP), thought to be a metabolite of hCG that is excreted into urine, has recently been shown to be elevated in Down syndrome pregnancies. We sought to examine urinary UGP levels in preeclamptic and normotensive pregnant women.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0378-7346
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
45
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
24-8
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:9473159-Adult,
pubmed-meshheading:9473159-Case-Control Studies,
pubmed-meshheading:9473159-Chorionic Gonadotropin, beta Subunit, Human,
pubmed-meshheading:9473159-Cohort Studies,
pubmed-meshheading:9473159-Female,
pubmed-meshheading:9473159-Humans,
pubmed-meshheading:9473159-Peptide Fragments,
pubmed-meshheading:9473159-Pilot Projects,
pubmed-meshheading:9473159-Pre-Eclampsia,
pubmed-meshheading:9473159-Pregnancy,
pubmed-meshheading:9473159-Reference Values
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Urinary gonadotropin peptide levels in preeclamptic and normotensive pregnant women. Results from a pilot case-control study.
|
| pubmed:affiliation |
Center for Perinatal Studies, Swedish Medical Center, Seattle, Wash. 98104, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|